- Alle
- Pressemitteilungen
- Empfehlungen
- Chartanalysen
- Berichte
| Zeit | Aktuelle Nachrichten Sprache:
Alle DE EN | Leser | Medien | ||
|---|---|---|---|---|---|
| 24.04. | Genetic Analysis AS: Notice of Annual General Meeting 2024 | 1 | Cision News | ||
| 19.04. | Genetic Analysis AS: Mandatory notification of trade - Primary Insider | 1 | Cision News | ||
| 11.03. | Genetic Analysis AS: Mandatory notification of trade - Primary Insider | 1 | Cision News | ||
| 26.02. | Genetic Analysis AS: Genetic Analysis AS announces CE-IVDR marking for its GA-map® Sample Collection Kit | 1 | Cision News | ||
| 10.01. | GENETIC ANALYSIS AS: Genetic Analysis subsequent offering to existing shareholders has now been registered with the Norwegian Register of Business Enterprises | 1 | Cision News | ||
| 27.12.23 | GENETIC ANALYSIS AS: Genetic Analysis announces final outcome of the subsequent offering to existing shareholders | 2 | Cision News | ||
| 22.12.23 | GENETIC ANALYSIS AS: Genetic Analysis announces preliminary outcome of the subsequent offering to existing shareholders | 2 | Cision News | ||
| 21.12.23 | GENETIC ANALYSIS AS: Genetic Analysis partners up to enter the consumer market with GA-map® | 2 | Cision News | ||
| 13.12.23 | GENETIC ANALYSIS AS: Genetic Analysis summarizes this year's product development activities and looks ahead to 2024 | 2 | Cision News | ||
| 11.12.23 | GENETIC ANALYSIS AS: Today, the subscription period in Genetic Analysis subsequent offering begins | 2 | Cision News | ||
| 08.12.23 | GENETIC ANALYSIS AS: Genetic Analysis publishes information memorandum relating to the previously announced subsequent offering | 1 | Cision News | ||
| 08.12.23 | GENETIC ANALYSIS AS: Genetic Analysis announces final number of subscription rights received per existing share in the previously announced subsequent offering | 1 | Cision News | ||
| 07.12.23 | Spotlight Stock Market: Market Notice 269/23 - Information regarding the subscription right from Genetic Analysis AS | 1 | Cision News | ||
| 05.12.23 | XFRA CAPITAL ADJUSTMENT INFORMATION - 05.12.2023 | 684 | Xetra Newsboard | Das Instrument 8QE KYG2007L2040 CAZOO GROUP A DL-,0001 EQUITY wird cum Kapitalmassnahme gehandelt am 05.12.2023 und ex Kapitalmassnahme am 06.12.2023 The instrument 8QE KYG2007L2040 CAZOO GROUP A DL-... ► Artikel lesen | |
| 30.11.23 | GENETIC ANALYSIS AS: Genetic Analysis announces terms of the previously announced subsequent offering to shareholders of up to appr. NOK 9 million | 1 | Cision News | ||
| 20.11.23 | Genetic Analysis AS: Mandatory notification of trade | 1 | Cision News | ||
| 20.11.23 | Genetic Analysis AS: Minutes from the Extraordinary General Meeting | 1 | Cision News | ||
| 16.11.23 | GENETIC ANALYSIS AS: Presentation of GA-map® by Genetic Analysis sparks great interest at xMAP® Connect EMEA in Amsterdam | 1 | Cision News | ||
| 15.11.23 | Spotlight Stock Market: Market Notice 247/23- Last day of trading in Genetic Analysis AS's subscription option TO 2 | 1 | Cision News | ||
| 06.11.23 | GENETIC ANALYSIS AS: Notice of Extraordinary General Meeting 2023 | 1 | Cision News |
20 Nachrichten in den letzten 12 Monaten
| Unternehmen / Aktien | Aktienkurs | % | Top-Nachrichten | ||
|---|---|---|---|---|---|
| BAXTER | 34,815 | +1,19 % | Baxter-Aktie: Kurs steigt nur geringfügig (37,7621 €) | Am US-amerikanischen Aktienmarkt ist die Aktie von Baxter gegenwärtig unauffällig. Die Aktie notiert derzeit bei 40,45 US-Dollar. Einen geringen Wertanstieg von 0,20 Prozent zeigt die Kurstafel für... ► Artikel lesen | |
| MOBILE-HEALTH NETWORK SOLUTIONS | 22,070 | 0,00 % | Mobile-health Retreats on Opening New Pharmacy | ||
| ATRICURE | 22,210 | 0,00 % | AtriCure Reports First Quarter 2024 Financial Results | MASON, Ohio--(BUSINESS WIRE)--AtriCure, Inc. (Nasdaq: ATRC), a leading innovator in surgical treatments and therapies for atrial fibrillation (Afib), left atrial appendage (LAA) management and... ► Artikel lesen | |
| FRESENIUS | 28,210 | 0,00 % | Fresenius: Schöner Aufwärtstrend! | Der RuMaS Express-Service und die RuMaS Trading-Tipps bieten für Anfänger, erfahrene Anleger und Vieltrader gleichermaßen ein breites und qualitativ ausgezeichnetes Angebot an Börsentipps. Für Börsenneulinge... ► Artikel lesen | |
| PROCEPT BIOROBOTICS | 61,69 | 0,00 % | PROCEPT BioRobotics Corp - 10-Q, Quarterly Report | ||
| RXSIGHT | 59,63 | 0,00 % | RxSight, Inc. Reports Fourth Quarter and Full Year 2023 Financial Results | ALISO VIEJO, Calif., Feb. 28, 2024 (GLOBE NEWSWIRE) -- RxSight, Inc., an ophthalmic medical device company dedicated to providing high-quality customized vision to patients following cataract surgery... ► Artikel lesen | |
| CARL ZEISS MEDITEC | 98,20 | +0,87 % | Neue 11,00% Aktienanleihe mit Barriere auf Carl Zeiss Meditec in Zeichnung | München (www.anleihencheck.de) - Die Experten vom Zertifikate-Team der Bank Vontobel Europe AG bieten eine neue Aktienanleihe (ISIN DE000VD4NFC9/ WKN VD4NFC) mit Barriere auf die Aktie von Carl Zeiss... ► Artikel lesen | |
| AGILITI | 10,070 | 0,00 % | DigitalOcean to replace Agiliti in S&P SmallCap Index | ||
| FRESENIUS MEDICAL CARE | 40,360 | +0,40 % | JEFFERIES stuft FMC FRESENIUS MEDICAL CARE AG & CO KGAA auf 'Underperform' | NEW YORK (dpa-AFX Analyser) - Das Analysehaus Jefferies hat das Kursziel für FMC vor Quartalszahlen von 29 auf 32 Euro angehoben und die Einstufung auf "Underperform" belassen. Nachdem sich der Dialysespezialist... ► Artikel lesen | |
| PRIVIA HEALTH GROUP | 18,410 | 0,00 % | Privia Health Group, Inc.: Privia Health Reports Fourth Quarter and Full-Year 2023 Financial Results | Achieved All 2023 Operating and Financial Guidance MetricsImplemented Providers +19.4% compared to Year-End 2022Introduces Full-Year 2024 GuidanceProactive Steps to Limit Downside Risk Arrangements... ► Artikel lesen | |
| SIEMENS HEALTHINEERS | 51,78 | +1,13 % | Siemens Healthineers: Aktie klettert im DAX - das beflügelt | Die Aktie von Siemens Healthineers sichert sich am Montag einen der Spitzenränge im DAX. Auftrieb verleihen positive News vom Konkurrenten Philips. Dessen Aktie zieht mittlerweile mit einem Plus von... ► Artikel lesen | |
| BRIGHTSPRING HEALTH SERVICES | 11,060 | 0,00 % | BrightSpring Health Services, Inc. Reports First Quarter 2024 Financial Results and Increases Full Year 2024 Guidance | LOUISVILLE, Ky., May 02, 2024 (GLOBE NEWSWIRE) -- BrightSpring Health Services, Inc. ("BrightSpring" or the "Company") (NASDAQ: BTSG), a leading provider of home and community-based health services... ► Artikel lesen | |
| PROGYNY | 32,070 | 0,00 % | Progyny, Inc. Announces Third Quarter 2023 Results | Record Quarterly Revenue of $280.9 Million, Reflecting 37% Growth Over the Prior Year PeriodRaises Full Year Revenue and Earnings GuidanceStrong Sales Season Produces 1.3 Million New Covered Lives... ► Artikel lesen | |
| GENEDX | 19,490 | 0,00 % | Pre-market Movers: Cyclacel Pharmaceuticals, Marin Software, GeneDx, Sensata Technologies, Lichen China | INDIANAPOLIS (dpa-AFX) - The following are some of the stocks making big moves in Tuesday's pre-market trading (as of 08.05 A.M. ET).In the Green Cyclacel Pharmaceuticals, Inc. (CYCC) is up... ► Artikel lesen | |
| ADAPTHEALTH | 10,350 | 0,00 % | AdaptHealth Corp. Announces Fourth Quarter and Full-Year 2023 Results and Provides Initial 2024 Outlook | PLYMOUTH MEETING, Pa.--(BUSINESS WIRE)--AdaptHealth Corp. (NASDAQ: AHCO) ("AdaptHealth" or the "Company"), a national leader in providing patient-centered, healthcare-at-home solutions including... ► Artikel lesen |
Das Unternehmen GENETIC ANALYSIS AS kann der Branche Gesundheitswesen zugeordnet werden. Mit einer aktuellen Kursveränderung von 0,000 (0,00 %) liegt der Kurs bei 0,041 Euro.
VerkaufenHaltenKaufen
■ Verkaufen
■ Halten
■ Kaufen
Sie erhalten auf FinanzNachrichten.de kostenlose Realtime-Aktienkurse von und
